abrupt market withdrawal of Adderall XR (mixed amphetamines)

March 2005

There's controversy over Health Canada's abrupt market withdrawal of Adderall XR (mixed amphetamines).

Canadian authorities stopped the sale of Adderall XR due to 20 reports of sudden death in children and adults.

Surprisingly, some of these deaths occurred in patients WITHOUT any apparent heart abnormalities...and taking usual doses.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

figuring out the actual risk of COX-2 inhibitors
Are all inhalation devices equally effective
Cardiology concerns about Plavix and GI bleeding
abrupt market withdrawal of Adderall XR (mixed amphetamines)
new SSRI antidepressant called Cipralex
guidelines for treating migraines in CHILDREN
Cholesterol warning about new safety data on Ezetrol
HIV & AIDS new recommendations for preventing HIV immediately AFTER an exposure
Gastroenterology whether chronic use of stimulant laxatives is harmful
Gastroenterology Is it important for patients to avoid aspirin and NSAIDs before fecal occult blood tests (Hemoccult, etc)
Gastroenterology if drug doses need to be altered after gastric bypass surgery
Dermatology benzoyl peroxide often works as well as oral minocycline for mild to moderate facial acne
Diabetes new long-acting insulin called Lantus
Drug Testing People are asking about drug testing